| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
folate hydrolase 1 | 0.453 | 0.885 | 6.2E-09 |
|
disease | 0.100 | None | 1.000 | 47 | 0 | 2009 | 2020 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.100 | None | 0.963 | 27 | 0 | 2003 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 20 | 0 | 1997 | 2019 | ||||||||
|
aminopeptidase puromycin sensitive | 0.519 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 2008 | 2020 | ||||||||
|
PLAG1 zinc finger | 0.493 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 2008 | 2020 | ||||||||
|
protein S | 0.467 | 0.846 | 4.7E-04 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 2008 | 2020 | ||||||||
|
phosphoserine aminotransferase 1 | 0.478 | 0.846 | 1.1E-08 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 2008 | 2020 | ||||||||
|
fibronectin type III and SPRY domain containing 1 | 0.486 | 0.808 | 0.25 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
GLI pathogenesis related 1 | 0.636 | 0.500 | 2.1E-14 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2010 | ||||||||
|
fibronectin type III and SPRY domain containing 1 like | 0.488 | 0.808 | 0.23 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
proteasome 20S subunit alpha 1 | 0.711 | 0.308 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
acid phosphatase 3 | 0.525 | 0.731 | 2.5E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
paired like homeodomain 2 | 0.489 | 0.808 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
SATB homeobox 1 | 0.525 | 0.769 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
histone deacetylase 9 | 0.439 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
aldo-keto reductase family 1 member C3 | 0.529 | 0.769 | 7.6E-24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
speckle type BTB/POZ protein | 0.597 | 0.500 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
bone gamma-carboxyglutamate protein | 0.462 | 0.846 | 4.6E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
steroid 5 alpha-reductase 1 | 0.631 | 0.538 | 1.2E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 |